Renova Therapeutics
PrivateLast Round
Grant
Jun 1, 2022
Total Funding Raised
$9.12M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Renova Therapeutics operates in Healthcare & Life Sciences and is based in Carlsbad, California. Its latest recorded funding round was a Grant round in June 2022.
Renova Therapeutics is a biotechnology company that develops definitive, one-time gene therapies to restore the health of people suffering from chronic diseases such as congestive heart failure and type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renova Therapeutics Comparables
Compare Renova Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medera | 83% | |
| Bayer AG | 80% | |
| XyloCor Therapeutics | 77% |
For institutional investors. Book with your work email.
Renova Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2022 | ||||
| Grant | Feb 23, 2016 | ||||
| Series C | Sep 30, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Renova Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| BioBrit | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 109% MoM, reaching 2K.
- Jul 2, 2025
Monthly visitors grew 36% MoM, reaching 1.9K.
For institutional investors. Book with your work email.
Renova Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Renova Therapeutics's valuation, stock price, and market status.
Is Renova Therapeutics a public or private company?
Renova Therapeutics is a private company.
What is the current stock price of Renova Therapeutics?
Renova Therapeutics is a private company, so its shares have no public market price. Caplight tracks Renova Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Renova Therapeutics worth (valuation)?
Valuation information for Renova Therapeutics is not publicly available.
Can I buy Renova Therapeutics stock?
Renova Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Renova Therapeutics's last funding round?
Renova Therapeutics's most recent funding round was Grant on June 1, 2022.
Who are the main investors in Renova Therapeutics?
Key investors in Renova Therapeutics include NIH RADx, National Heart, Lung, and Blood Institute, BioBrit.
Will Renova Therapeutics IPO soon?
No public IPO plans have been announced for Renova Therapeutics.
How can I track Renova Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Renova Therapeutics's shares on secondary markets.